Zheng Cai Selected Research

Zheng Cai Research Topics

Disease

14	Neoplasms (Cancer) 07/2022 - 01/2010
7	Glioma (Gliomas) 07/2022 - 01/2015
4	Thrombocytopenia (Thrombopenia) 01/2023 - 09/2015
2	Hemorrhage 01/2023 - 01/2021
2	Ischemic Stroke 01/2023 - 10/2019
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 12/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2021
2	Fistula 11/2021 - 01/2021
2	COVID-19 01/2021 - 10/2020
2	Infections 10/2020 - 01/2019
2	Thrombosis (Thrombus) 10/2020 - 09/2015
2	Cerebral Infarction 10/2019 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 01/2019
2	Meningioma (Meningiomas) 08/2017 - 01/2017
1	Adenoma (Adenomas) 01/2023
1	Inflammation (Inflammations) 01/2022
1	Cysts 11/2021
1	Neurologic Manifestations (Neurological Manifestations) 11/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Heart Failure 01/2021
1	Pulmonary Embolism 01/2021
1	Diarrhea 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Latent Tuberculosis 01/2021
1	Ascites 01/2021
1	Arteriovenous Fistula 01/2021
1	Paralysis (Palsy) 01/2021
1	Liver Failure 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 03/2020
1	Acute Promyelocytic Leukemia 03/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Pancreatitis 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2010
4	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 09/2015
4	AntibodiesIBA 01/2023 - 09/2015
4	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2015
3	Platelet Factor 4IBA 01/2023 - 09/2015
3	AntigensIBA 01/2023 - 07/2016
3	Long Noncoding RNAIBA 08/2019 - 01/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 09/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2015
2	GlycosaminoglycansIBA 07/2016 - 09/2015
2	Phosphotransferases (Kinase)IBA 12/2012 - 12/2010
1	FructoseIBA 01/2023
1	Culture MediaIBA 01/2023
1	Sucrose (Saccharose)IBA 01/2023
1	Resistant StarchIBA 01/2023
1	MelatoninIBA 01/2023
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2023
1	PrebioticsIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	NAD (NADH)IBA 07/2022
1	Sirtuin 1IBA 07/2022
1	Nicotinamide N-MethyltransferaseIBA 07/2022
1	N-nitroso-N-methyltyramine (NNMT)IBA 07/2022
1	AlbuminsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Adenosine DeaminaseIBA 01/2022
1	Carvedilol (Coreg)FDA LinkGeneric 01/2021
1	GelatinIBA 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021
1	EmulsionsIBA 01/2021
1	Ethiodized Oil (Ethiodol)FDA Link 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	InterferonsIBA 01/2021
1	IodineIBA 01/2021
1	Iodized OilIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	heparin-binding hemagglutininIBA 01/2021
1	PowdersIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 10/2020
1	Blocking AntibodiesIBA 10/2020
1	CytokinesIBA 10/2020
1	O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA 08/2020
1	Arsenic Trioxide (Trisenox)FDA Link 03/2020
1	Liposomes (Liposome)IBA 01/2020
1	Amylases FDA Link 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	Volatile Fatty AcidsIBA 10/2019
1	LipidsIBA 10/2019
1	Butyric Acid (Butanoic Acid)IBA 10/2019
1	Competitive Endogenous RNAIBA 08/2019
1	graphene oxideIBA 07/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2019

Therapy/Procedure

11	Therapeutics 01/2023 - 12/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 08/2018
2	Intranasal Administration 01/2021 - 12/2011
2	Lasers (Laser) 08/2020 - 07/2019
1	Operative Time 01/2023
1	Molecular Targeted Therapy 01/2023
1	Ligation 11/2021
1	Operative Surgical Procedures 11/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2020
1	Extracorporeal Membrane Oxygenation 10/2020
1	Transplantation 10/2019
1	Oral Administration 10/2019